Multiple Choice
All of the following are possible mechanisms for the pathogenesis in TTP except:
A) TTP plasma is deficient in a platelet-aggregating factor inhibitor
B) Large vWF multimers promote platelet agglutination.
C) Endothelial cell damage via a plasma factor results in platelet adhesion.
D) Inhibition of cyclo-oxygenase (aspirin-like)
E) Deficiency of prostacyclin (PGI2) synthesis and release leading to platelet aggregation and thrombosis
Correct Answer:

Verified
Correct Answer:
Verified
Q20: Spontaneous serious complications such as epistaxis, gingival
Q21: Laboratory findings in the storage pool deficiencies
Q22: Which laboratory findings differentiate vWD from Glanzmann's
Q23: Glanzmann's thrombasthenia and congenital afibrinogenemia are qualitative
Q24: A patient whose serum contains or is
Q26: The treatment of choice for chronic ITP
Q27: Treatment of patients with Glanzmann's thrombasthenia who
Q28: _ is an immune disorder that presents
Q29: Thrombocytosis may result from which of the
Q30: Quantitative congenital disorders that produce hypoplasia of